White House Withdraws Dr. Heidi Overton's FDA Nomination a Day Before Committee Vote
The White House pulled Dr. Heidi Overton's nomination to lead the Food and Drug Administration one day before a Senate committee vote, after Republican opposition left her short of the votes she needed.
Newsnibs Staff
- 2026-11-18
- Updated 6:14 AM UTC
(Washington, United States)
The White House withdrew Dr. Heidi Overton's nomination to be commissioner of the Food and Drug Administration on Tuesday, one day before the Senate Health, Education, Labor and Pensions Committee was scheduled to vote on advancing it. A White House official confirmed the decision in four words: "Can confirm nomination pulled." Overton, a physician and White House domestic policy adviser, had been struggling to line up the Republican votes she needed.
President Trump nominated her in August to bring stability to an agency that has had no permanent commissioner since Dr. Marty Makary left in May. Kyle Diamantas, an attorney, has run the FDA in an acting capacity since then. Overton is a preventive medicine doctor who was previously chief policy officer at the America First Policy Institute.
The committee arithmetic was tight. Republicans hold 12 seats and Democrats hold 11, and no Democrats were expected to support her, so Overton needed every Republican. Committee Chairman Bill Cassidy of Louisiana, Susan Collins of Maine, Lisa Murkowski of Alaska and Josh Hawley of Missouri had each opposed her or declined to commit. Collins said she was undecided and wanted "to get some answers on various things."
Cassidy, who is leaving the chairmanship, had voiced "strong concerns" about Overton's role in changes to childhood vaccine recommendations. He called her support for Trump's proposal to separate combination vaccines, such as the measles, mumps and rubella shot, "almost disqualifying," and he questioned her experience. He also acknowledged the trade-off between a "permanent" commissioner and a series of short-term administrators. Hawley cited her avoidance of questions about a safety study on mifepristone, the FDA-approved abortion drug.
Overton drew criticism from several directions at once. She has praised the Supreme Court's overturning of Roe v. Wade and called for strict limits on medication abortion, yet anti-abortion activists questioned her position on regulating mifepristone. Supporters of Health and Human Services Secretary Robert F. Kennedy Jr.'s Make America Healthy Again movement said she put the health and agriculture industries ahead of their agenda. Calley Means, a leader of that movement, called her a "block to MAHA policies." Her defenders point to her medical training and to endorsements from two former FDA commissioners. Senators of both parties also pressed her on whether she would keep the agency scientifically independent of Trump, particularly on his claims about the safety of childhood vaccines.
Makary's own exit remains disputed. Some accounts describe a departure in May, while others say the White House removed him. In a statement on November 8, Makary said he had refused to approve products he believed appealed to children, and he attributed his ouster to White House pressure over flavored vapes. He had also faced pressure over delays in restricting online prescriptions of mifepristone.
The FDA is nearing a decision on its safety review of mifepristone, which is scheduled to be completed in March. Democrats are set to take control of the Senate in January, which would have required the White House to renominate Overton, and Republicans want to confirm the remaining presidential nominees before the handover. The White House has previously pulled other health-related nominations, including those for the Centers for Disease Control and Prevention and for surgeon general. The CDC went nearly a year without a permanent director before Dr. Erica Schwartz was confirmed in August.
The FDA oversees products that account for roughly 20% of consumer spending. Since Trump took office, it has lost about 20% of its workforce to layoffs, buyouts and resignations.
Photo by Andy He on Unsplash